PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 44 results · Patient Organisations  · Clear
🔒 Subscribers only
AUTH/3907/05/24
Patient Organisations Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Jazz Pharmaceuticals UK breached transparency rules for patient organisation-funded family guide (AU
An anonymous, contactable health professional complained about a patient organisation “Family Guide” booklet funded by Jazz via an educational grant.The complainant alleged the funding declarat…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3923/6/24
Patient Organisations Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Complainant v GSK
An anonymous, contactable complainant (health professional) alleged that GSK COPD representatives’ Trelegy sales aid(s) used throughout 2023 promoted Trelegy Ellipta for an unlicensed indication.…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3897/5/24
Patient Organisations Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Roche breached Clause 25.3 after BBC radio programme lacked clear sponsorship declaration from the o
An anonymous complainant alleged that a BBC radio/audio programme about a campaign sponsored by Roche featured interviews with campaign partners but did not declare Roche’s involvement from the o…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3890/4/24
Patient Organisations Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
Three articles in the business section of a national newspaper were based on an interview with a senior employee of Novo Holdings (controlling shareholder of Novo Nordisk A/S). The articles were …
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3742/2/23
Patient Organisations Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Takeda UK
Takeda UK made a voluntary admission about a letter sent to 266 UK-based suppliers (7 February 2023) about new global payment terms.The letter was created and distributed by Takeda’s Global Procu…
Clauses: 9.1
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3752/3/23
Patient Organisations Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk voluntary admission
The PMCPA Director took up a complaint following five Observer articles (print/online, 12 March 2023 and 2 April 2023) critical of Novo Nordisk’s activities around semaglutide for weight loss (We…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3803/07/23
Patient Organisations Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
GSK press release on dostarlimab
An anonymous complainant alleged GSK promoted Jemperli (dostarlimab) via a press release about an MHRA Early Access to Medicines Scheme (EAMS) positive scientific opinion for endometrial cancer.The…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3847/11/23
Patient Organisations Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Novo Nordisk
Novo Nordisk made a voluntary admission about undisclosed transfers of value (ToVs) of approximately £7.8 million over a three-year period (2020–2022) selected as part of an internal investigati…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3717/12/22
Patient Organisations Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Public complaint about weight-loss media coverage
A member of the public complained that five media articles about weight loss effectively promoted Novo Nordisk prescription-only medicines (including Wegovy/Ozempic) to the public as a safe way to …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3461/1/21
Patient Organisations Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Santen
A health professional complained about a wrap-around journal advertisement for Cosopt (dorzolamide and timolol) in The Ophthalmologist (Dec 2020) (ref PP-CSPT-UK-0006).The wrap-around was visible t…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3519/5/21
Patient Organisations Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Pfizer press release on COVID-19 vaccine efficacy ruled misleading for omitting absolute risk contex
A member of the public complained about a Pfizer/BioNTech press release dated 2 December 2020 discussing COVID-19 vaccine efficacy.The complainant alleged the release presented relative risk reduct…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3575/11/21
Patient Organisations Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Biogen
An anonymous ex-employee complained about a local senior leader’s conduct in 2018 (the individual had since left Biogen).The complainant provided an internal email sent to a broad “site team”…
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3389/9/20
Patient Organisations Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Sandoz
Sandoz made a voluntary admission that copies of the September 2020 edition of Guidelines in Practice were sent in transparent wrappers instead of the usual opaque polywrap.A bound outsert (wrapped…
Clauses: 9.1
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3398/10/20
Patient Organisations Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
MSD
Merck Sharp & Dohme (MSD) placed a promotional formulary decision guide for Steglatro (ertugliflozin) (ref GB-STE-00367) inside the September 2020 distribution of Guidelines in Practice, a jour…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3439/12/20
Patient Organisations Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Amgen disease awareness
A health professional complained about a national newspaper advertisement placed by Amgen Ltd (ref GB-PRO-0920-00028).The ad showed an older woman and stated: “Are you up to date with your osteop…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3334/4/20
Patient Organisations Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Rayner
A health professional received a posted copy of Eye News with a wraparound “bellyband” advertisement for Ilube (acetylcysteine eye drops).The advertisement was visible through the unopened, tra…
Clauses: 9.1
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3362/6/20
Patient Organisations Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche
Roche voluntarily admitted that a promotional email for Tecentriq (atezolizumab) was inadvertently sent by a third-party agency to members of the public.The email was intended for UK oncologists an…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/2983/10/17
Patient Organisations Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Celgene corporate brochure
An anonymous, non-contactable complainant (appearing to be a clinician) alleged a Celgene booklet, “Life We’re working on it” (ref UK-CELG160202), promoted Abraxane (protein bound paclitaxel)…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2939/2/17
Patient Organisations Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Astellas UK & Astellas Europe
Astellas UK and Astellas Europe made a joint voluntary admission that prescribing information (PI) used in UK promotion was incomplete for multiple medicines. The issue was discovered during routin…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2886/11/16
Patient Organisations Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Vifor
Pharmacosmos complained about a Vifor Pharma UK promotional leavepiece for Ferinject (iron carboxymaltose) titled “Their world awaits” (ref UK/FER/16/0116).The front page included a red box sta…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2874/9/16
Patient Organisations Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Shield
A health professional complained about a one-page Feraccru (ferric maltol) journal advertisement by Shield Therapeutics UK (Gastrointestinal Nursing, September 2016; ref UK/FER/2016/004f).The ad st…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2706/3/14
Patient Organisations Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Tillotts detail aid on Octasa vs Asacol dissolution
Warner Chilcott UK (marketer of Asacol) complained about a Tillotts Pharma UK detail aid for Octasa (mesalazine MR), ref UK/OC/0002/0114.The complaint alleged the detail aid breached an undertaking…
Clauses: NONE
2014 🔒 Subscribe
🔒 Subscribers only
AUTH/2407/6/11
Patient Organisations Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
GP complaint about alleged disguised promotion of Pradaxa in The British Journal of Cardiology (No b
A general practitioner complained that the June 2011 edition of The British Journal of Cardiology contained disguised promotion of Pradaxa (dabigatran).The concern related to stroke/systemic emboli…
Clauses: NONE
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2404/5/11
Patient Organisations Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Boehringer Ingelheim
A general practitioner complained about UK newspaper articles (Daily Mail, The Telegraph, Daily Express) on 5 April 2011 that discussed Pradaxa (dabigatran) for preventing stroke—an unlicensed in…
Clauses: NONE
2011 🔒 Subscribe
1 2 Next → Page 1 of 2 — 44 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews